NASDAQ / LIVE COMPANY INTELLIGENCE

Sionna Therapeutics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERSION
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / SION COVERAGE

What’s moving Sionna Therapeutics, Inc. now

Current reporting with the operating signal separated from the noise.

01
Sionna Therapeutics, Inc. (SION) Receives a Rating Update from a Top Analyst

Sionna Therapeutics, Inc. (SION) Receives a Rating Update from a Top Analyst

The story matters when it changes Sionna Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Janux Therapeutics Inc (JANX)

Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Janux Therapeutics Inc (JANX)

The story matters when it changes Sionna Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Sionna Therapeutics, Inc. (SION) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Sionna Therapeutics, Inc. (SION) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

The story matters when it changes Sionna Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Sionna Therapeutics, Inc.: Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in ...

Sionna Therapeutics, Inc.: Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in ...

The story matters when it changes Sionna Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Sionna Therapeutics, Inc. (SION) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Sionna Therapeutics, Inc. (SION) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

The story matters when it changes Sionna Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
06
All You Need to Know About Sionna Therapeutics, Inc. (SION) Rating Upgrade to Buy

All You Need to Know About Sionna Therapeutics, Inc. (SION) Rating Upgrade to Buy

The story matters when it changes Sionna Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
07
Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month

Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month

The story matters when it changes Sionna Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest SION filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-12 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-05 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-02 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-18 · Period 2026-06-17SEC ↗8-KMaterial company eventFiled 2026-05-12 · Period 2026-05-12SEC ↗8-KMaterial company eventFiled 2026-03-02 · Period 2026-03-02SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-27 · Period 2026-06-17SEC ↗4Official SEC filingFiled 2026-07-09 · Period 2026-07-07SEC ↗
EARNINGS / QUARTERLY TRACKER

Sionna Therapeutics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.